Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
Not yet recruiting · NCT07359963 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Not yet recruiting | Early phase 1 | 2026-01-22 | NCT07359963 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regend Therapeutics | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Fourth Hospital of Zhejiang University School of Medicine | Yiwu | China | 2 |